Evidence map›Paper›PMID 29581613›Full record

Trial reportNagoya journal of medical science2018

Intra-articular platelet-rich plasma (PRP) injections for treating knee pain associated with osteoarthritis of the knee in the Japanese population: a phase I and IIa clinical trial.

Yu Taniguchi, Tomokazu Yoshioka, Akihiro Kanamori, Katsuya Aoto, Hisashi Sugaya, Masashi Yamazaki

2 registry-linked trialsOpen access · greenAbstract readClinical Trial, Phase IClinical Trial, Phase II
In one paragraph

Trial report in Nagoya journal of medical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04754685 nacompletednot on this mapstarted 2019, after this paper: background citation

Assessments of Therapeutic Effects of Platelet-rich Plasma in Knee Osteoarthritis: Possible Role of Inflammatory Cytokines

TypeinterventionalSponsorSouth Valley UniversityRan2019 to 2020Enrolled90ConditionsKnee OsteoarthritisArmsIntra-articular injection of platelet-rich plasma
NCT05080075 early_phase1completednot on this mapstarted 2021, after this paper: background citation

Platelet Rich Plasma in Knee Osteoarthritis: Establishing Clinical Guidelines to Predict and Maximize Outcomes

TypeinterventionalSponsorUniversity of Toledo Health Science CampusRan2021 to 2023Enrolled33ConditionsKnee OsteoarthritisArmsPlatelet Rich Plasma Injection
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Freeze-dried noncoagulating platelet-derived factor concentrate is a safe and effective treatment for early knee osteoarthritis.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Platelet Concentrates in Musculoskeletal Medicine.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yu TaniguchiDepartment of Orthopedic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Tomokazu YoshiokaDepartment of Orthopedic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Akihiro KanamoriDepartment of Orthopedic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Katsuya AotoDepartment of Orthopedic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Hisashi SugayaDepartment of Orthopedic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Masashi YamazakiDepartment of Orthopedic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
University of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intra-articular platelet-rich plasma (PRP) injection has been found to be effective for treating osteoarthritis in patients from Western countries; however, the safety and efficacy of PRP have not been sufficiently investigated in Japanese patients. The present study aimed to evaluate the safety and feasibility of intra-articular PRP injection in Japanese patients with knee osteoarthritis. PRP without white blood cells was prepared using a single-spin centrifuge (PRGF-Endoret; BTI Biotechnology Institute, Vitoria, Spain). A 6-mL PRP volume was injected in the knee joint three times at 1 week intervals. All patients were prospectively evaluated before intervention and at 1, 3, and 6 months after the treatment. Adverse events, the Visual Analog Scale (VAS) pain score, Japanese Knee Osteoarthritis Measure (JKOM) score and Japanese Orthopedic Association score were evaluated. Ten patients (all women; average age, 60.6 years) were treated. Only minor adverse events after injection were noted, and symptoms resolved within 48 hours after the injection. The average VAS pain scores were 71.6 mm and 18.4 mm at baseline and the 6-month follow-up, respectively (P < 0.05). At the 6-month follow-up, 80% of patients had a decrease in the VAS pain score of 50% or more. The average JKOM scores were 35.2 and 14.3 at baseline and at the 1-month follow-up, respectively (P < 0.05). Intra-articular PRP injection likely represents a safe treatment option for Japanese patients with mild-to-moderate knee osteoarthritis, and has the potential to relieve pain for up to 6 months, but further study is needed to verify the efficacy.

Indexed as

Platelet-Rich PlasmaAgedHumansInjections, Intra-ArticularKnee JointMiddle AgedOsteoarthritis, KneePain Measurementintra-articular injectionknee osteoarthritisplatelet-rich plasmatreatment safety

Identifiers

PMID29581613
PMCPMC5857500
OpenAlexW2982418037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.